Physician profile
Edward Lee
NPI 1528697620
$3,750.38
in general payments reported to CMS, 2019-2025
11 companies · $3,625 in 2025
The $3,625 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $65.08 · 2024: $59.81 · 2025: $3,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $400 · Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $400.06 |
| Food and Beverage | $350.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $3,400.06 | 2025 | Novosorb Btm |
| Mimedx Group, INC. | $86.22 | 2025 | |
| Pfizer INC. | $71.56 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $42.24 | 2023 | Xarelto |
| Dexcom, INC. | $36.18 | 2023-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $21.37 | 2025 | |
| Sumitomo Pharma America, INC. | $20.85 | 2024 | Gemtesa |
| Exact Sciences Corporation | $20.27 | 2025 | Cologuard Collection Kit |
| Tolmar, INC. | $19.23 | 2025 | Jatenzo |
| Vifor Pharma, INC. | $16.50 | 2025 | Veltassa |
| Travere Therapeutics, INC. | $15.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.